You need to check the facts. Only one director has been on the Board since inception, all the other directors joined 2015 or later.
Nevertheless, many of the seed shareholders are still on the register and therefore must be confident of the success of the project.
There has never been a payment to directors for 10 years of accumulated services, but directors have been paid by way of shares in lieu of cash, at various times, all issued at a premium to the then prevailing latest equity raising cash price. All these issues to directors had ASIC approval prior to taking the proposed issue to directors, to shareholders for approval.
All expenses reimbursed via share allocations were issued at the prevailing cash equity issue price. Never were shares allocated or expenses reimbursed at half the issue price at listing. Check the prospectus!
- Forums
- ASX - By Stock
- AKO
- Ann: 2021 Bekisopa Drilling Programme Update
Ann: 2021 Bekisopa Drilling Programme Update, page-8
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AKO (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.06M |
Open | High | Low | Value | Volume |
12.5¢ | 12.5¢ | 12.5¢ | $40.78K | 326.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 43635 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 73965 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 43635 | 0.120 |
1 | 70000 | 0.115 |
1 | 100000 | 0.100 |
1 | 100000 | 0.090 |
1 | 150000 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 73965 | 1 |
0.135 | 40004 | 1 |
0.150 | 99796 | 4 |
0.155 | 36055 | 1 |
0.160 | 63967 | 1 |
Last trade - 12.02pm 12/11/2024 (20 minute delay) ? |
Featured News
AKO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online